Similar articles for PMID: 35697371

Year	Number of Results
2021	46
2022	130
2023	24
2024	0

1

Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity.

Edgerley S, Jeimy S, Zhu R. Edgerley S, et al. CMAJ. 2022 Jun 13;194(23):E807-E811. doi: 10.1503/cmaj.220435. CMAJ. 2022. PMID: 35697371 Free PMC article. No abstract available.

2

Immediate reactions after mRNA SARS-CoV-2 vaccination.

Jeimy S, Wong T, Song C. Jeimy S, et al. CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12. CMAJ. 2021. PMID: 34772737 Free PMC article. No abstract available.

3

Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.

Maeda M, Isawa T, Tada N. Maeda M, et al. Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4. Circ J. 2022. PMID: 34866122 Free article. No abstract available.

4

Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.

Fornaro M, Venerito V, Iannone F, Cacciapaglia F. Fornaro M, et al. J Rheumatol. 2022 Mar;49(3):334-335. doi: 10.3899/jrheum.210863. Epub 2022 Jan 15. J Rheumatol. 2022. PMID: 35033998 Free article. No abstract available.

5

Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination.

Hansbauer M, Fastantz E, Lutz J, Hasan A. Hansbauer M, et al. J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):502-503. doi: 10.1097/JCP.0000000000001577. Epub 2022 Aug 2. J Clin Psychopharmacol. 2022. PMID: 35916561 No abstract available.

6

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.

König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO. König M, et al. JAMA Neurol. 2022 Mar 1;79(3):307-309. doi: 10.1001/jamaneurol.2021.5109. JAMA Neurol. 2022. PMID: 35072702 Free PMC article.

7

[Vaccination against SARS-CoV-2 in patients with multiple sclerosis].

Costa Frossard-França L, García-Domínguez JM, Moreno-Torres I, Fortún J, Villar LM, Meca-Lallana V. Costa Frossard-França L, et al. Rev Neurol. 2021 Apr 1;72(7):250-260. doi: 10.33588/rn.7207.2021097. Rev Neurol. 2021. PMID: 33764494 Free article. Spanish.

8

BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study.

Lim XR, Leung BP, Sum CLL, Lim GH, Chua CG, Tu TM, Ramanathan K, Huang MY, Howe HS, Fan BE. Lim XR, et al. Am J Hematol. 2022 Apr;97(4):E141-E144. doi: 10.1002/ajh.26462. Epub 2022 Jan 19. Am J Hematol. 2022. PMID: 35015303 Free PMC article. No abstract available.

9

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

Chen GL, Li XF, Dai XH, Li N, Cheng ML, Huang Z, Shen J, Ge YH, Shen ZW, Deng YQ, Yang SY, Zhao H, Zhang NN, Zhang YF, Wei L, Wu KQ, Zhu MF, Peng CG, Jiang Q, Cao SC, Li YH, Zhao DH, Wu XH, Ni L, Shen HH, Dong C, Ying B, Sheng GP, Qin CF, Gao HN, Li LJ. Chen GL, et al. Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24. Lancet Microbe. 2022. PMID: 35098177 Free PMC article. Clinical Trial.

10

Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.

Wollina U, Chiriac A, Kocic H, Koch A, Brzezinski P. Wollina U, et al. Wien Med Wochenschr. 2022 Mar;172(3-4):63-69. doi: 10.1007/s10354-021-00876-0. Epub 2021 Aug 23. Wien Med Wochenschr. 2022. PMID: 34424434 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

171 results

Results by year